2BBBullish & Bearish
Health Care

Illumina, Inc. (ILMN) Stock Score & Signals

Illumina, Inc. (ILMN) trades on NASDAQ. It operates in the Health Care sector, Diagnostics & Research industry. Its current 2BB score is 50 out of 100.

About Illumina, Inc.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

2BB score and signals

Illumina, Inc.’s current 2BB score is 50 out of 100, built from the signal categories below.

SignalScoreReading
Activity66High
Momentum61Improving
Financial strength68Strong
Quality100Very Strong
Risk46Moderate

Company facts

CEOJacob Thaysen
HeadquartersSan Diego, California, United States
Founded1998
Employees8.62K
P/E ratio42.32
52-week range$88.00 – $231.81

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-02-031.5656$1.24B
2026-10-281.3816$1.17B
2026-07-301.2507$1.15B
2026-04-301.151.0754$1.09B$1.09B